Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P33527 (
ABCC1
)
1,164
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Multidrug resistance related protein 1 (MRP1/
ABCC1
) is an ABC transporter protein related to the extrusion of reduced glutathione (GSH), oxidized glutathione (GSSG) and GSH-conjugates, as well as leukotriene C(4) and cyclopentane prostaglandins. Inhibition of
ABCC1
activity impairs lymphocyte activation. The present work studied
ABCC1
expression and activity on a murine macrophage cell line, RAW 267.4 and the effects of
ABCC1
classical inhibitors, as well as GSH metabolism modulators, on LPS induced activation. Approximately, 75% of resting cells were positive for
ABCC1
and the classical
ABCC1
reversors (indomethacin, 0.1-2mM; probenecid, 0.1-10mM and MK571, 0.01-1mM) were able to enhance intracellular CFDA accumulation in a concentration-dependent manner, suggesting
ABCC1
inhibition. After LPS (100ng/ml) activation 50% of the population was positive for
ABCC1
, and this protein was still active. In LPS-activated cells,
ABCC1
activity was also impaired by BSO (1mM), an inhibitor of GSH synthesis. Conversely, GSH (5mM) reversed the BSO effect.
ABCC1
inhibition by indomethacin, probenecid or MK571 decreased LPS induced nitrite production in a concentration-dependent manner, the same result was observed with BSO and again GSH reversed its effect. The
ABCC1
reversors were also able to inhibit
iNOS
expression. In conclusion, LPS modulated the expression and activity of
ABCC1
transporters in RAW macrophages and inhibitors of these transporters were capable of inhibiting nitrite production suggesting a role for
ABCC1
transporters in the inflammatory process.
...
PMID:Multidrug resistance related protein (ABCC1) and its role on nitrite production by the murine macrophage cell line RAW 264.7. 1716 33